KCT0008468招募中Unknown
TAPIOCA: The frequency of T790M Alleles and their Prognostic sIgnificance during the follow-On treatment in EGFR M+ NSCLC patients who were treated with Afatinib and gefitinib
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1) Adult men and women over 19 years of age
- •2) Patients with EGFR mutation-positive advanced/metastatic non-small cell lung cancer who have been treated with afatinib or gefitinib for more than 6 months as first-line treatment
- •3) Patients with confirmed T790M mutation positive in tumor tissue or blood samples after failure of afatinib or gefitinib treatment as first-line treatment
- •4) Patients who received osimertinib as a second-line treatment after confirming acquired resistance T790M mutation
- •5) Patients with T790M allele frequency results obtained from tumor tissue or blood samples after afatinib or gefitinib treatment as the first treatment
排除标准
- •1) Patients unable to review medical records
- •2) Patients with brain metastases Patients with brain metastases
研究者
相似试验
已完成
不适用
T790M Mutation on ctDNA in Patients With NSCLC After EGFR-TKI FailureNon-small Cell Lung Cancer Stage IIINon-Small-Cell Lung Cancer MetastaticNCT02418234First People's Hospital of Hangzhou314
已完成
不适用
ltra-sensitive detection of the T790M mutation using droplet digital PCR and, efficacy and resistance analysis of EGFR tyrosine kinase inhibitors in pretreatment non-small cell lung cancer patients with EGFR mutation.on-small cell lung cancerJPRN-UMIN000027592Osaka City University Graduate School of Medicine Department of Respiratory Medicine74
尚未招募
不适用
The Prognostic Significance of Frequency of T790M Alleles and Blood NGS profile in EGFR T790M mutation patients with non-small cell lung cancer with Lazertinib treatment.NeoplasmsKCT0006896Asan Medical Center120
尚未招募
不适用
A clinical trial to study the frequency of genetic variations which influence the harmful levels of lead and mercury in children with the brain disorder called cerebral palsy.CTRI/2011/10/002036Dr Y K GUPTA250
尚未招募
不适用
The predictive marker for detecting T790M from a patient background before treatment in stage4 NSCLC patients harboring EGFR mutaiton (L858R and delition 19): HOPE-002non-small cell lung cancerJPRN-UMIN000041474Osaka International Cancer Institute250